查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1957263

分子動力學模擬軟體市場－全球產業規模、佔有率、趨勢、機會、預測：按類型、應用、最終用戶、地區和競爭對手分類，2021-2031年

Molecular Dynamics Simulation Software Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type, By Application, By End-user, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 180 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球分子動力學模擬軟體市場預計將從 2025 年的 6.6213 億美元成長到 2031 年的 15.3635 億美元，複合年成長率為 15.06%。

該軟體作為一個計算框架，透過數值求解牛頓運動方程式來模擬原子和分子的物理運動，並預測系統在特定時限內的行為。市場成長的主要促進因素是製藥業迫切需要加速藥物研發進程，以及化學工程領域對精確材料表徵的需求。此外，高效能運算基礎設施的日益普及使得研究機構能夠更精確地模擬大規模的生物系統，從而減少對資本密集物理實驗的依賴。

市場概覽
預測期 2027-2031
市場規模：2025年 6.6213億美元
市場規模：2031年 15.3635億美元
複合年成長率：2026-2031年 15.06%
成長最快的細分市場 GPU加速
最大的市場 北美洲

儘管取得了這些進展，但生命科學產業在管理和維護模擬過程中產生的大型複雜資料集方面仍面臨著巨大的挑戰。根據皮斯托亞聯盟的數據，到2024年，52%的生命科學專業人士會將低品質、管理不善的資料集視為有效採用先進計算研究技術的主要障礙。因此，確保資料完整性和互通性的陡峭學習曲線仍然是一個重大障礙，可能會阻礙市場成長和應用。

市場促進因素

藥物發現和設計領域模擬工具的廣泛應用正在從根本上重塑市場格局。企業正優先採用計算方法來降低傳統臨床試驗的高失敗率。透過利用分子動力學模擬受體結合親和性，企業可以在研發週期的早期階段識別出有前景的候選藥物，從而顯著降低研發成本。這種向虛擬實驗的策略轉變，得益於生技公司對模擬技術的大規模投資。例如，Xaira Therapeutics在2024年4月的新聞稿中宣布，已獲得10億美元的資金籌措，用於建立一個將生物數據生成與先進模擬產品開發相結合的平台，旨在重新定義藥物發現流程。

同時，人工智慧和機器學習演算法的融合提高了分子運動預測的準確性，並顯著縮短了計算時間。這些混合工作流程使研究人員能夠避免傳統的窮舉計算，從而快速分析更大、更複雜的系統。根據谷歌2024年5月發布的關於AlphaFold 3的技術BLOG，該公司更新後的模型與專用的基於物理的軟體工具相比，將蛋白質-配體相互作用的準確率提高了50%。這種效率在先進材料工程等眾多市場應用中至關重要。 2024年，微軟報告稱，其Azure Quantum Elements平台利用高性能人工智慧在短短80小時內篩檢了3,200萬種潛在的無機材料，展現了該技術為產業帶來的快速擴充性。

市場挑戰

管理和組織龐大而複雜的資料集的難度是限制全球分子動力學模擬軟體市場擴張的主要阻礙因素。隨著計算工具的進步，海量輸出資料不斷湧現，但要將其保持為可用於未來研究的狀態，則需要嚴格的組織和標準化。如果機構無法建立整合的資料管理框架，關鍵的研究資訊就會被困在孤立的系統中，導致難以檢驗模擬結果和有效訓練預測模型。這種分散化迫使調查團隊將寶貴的時間用於手動資料校正，而非進行高價值的發現，從而顯著降低了這些軟體解決方案所承諾的運作效率。

這種低效性為潛在買家帶來了巨大的進入門檻和擴充性障礙。根據皮斯托亞聯盟（Pistoia Alliance）預測，到2025年，57%的生命科學專業人士將把資料孤島視為有效利用實驗室資料的最大障礙。這些資料孤島阻礙了高階模擬所需的資訊無縫流動，使得決策者不願投資購買高階軟體授權。因此，企業優先考慮修復基礎架構而非採用先進的類比技術，從而減緩了市場成長。

市場趨勢

採用GPU加速的平行處理架構從根本上改變了分子動力學的運算環境，使其能夠以更高的吞吐量模擬大規模的生物系統。供應商正在加速最佳化資料中心GPU，以處理計算顯式溶劑模型中原子間作用力所需的大規模並行處理，從而克服傳統基於CPU的叢集的延遲限制。這項硬體進步使研究團隊能夠對複雜的聚合物結構（例如整個病毒衣殼）進行微秒模擬，而這在以前被認為在計算上是不可能的。根據Exxact公司2025年9月發布的「AMBER 24 NVIDIA GPU基準測試」報告，NVIDIA B200 SXM GPU在模擬衛星菸草花葉病毒系統時，每天的運行時間達到了114奈秒，比RTX 4090快了40%。

同時，向基於雲端的高效能運算平台的轉變，正在普及這些先進的模擬能力，並解決管理Petabyte級軌跡資料的關鍵挑戰。透過將工作負載遷移到雲端，組織可以利用彈性基礎設施來滿足不斷成長的模擬需求，而無需投入大量資金維護本地超級電腦，同時還能集中存取標準化的公開資料集。這種轉變正在推動開放科學的新時代，大規模的模擬資料儲存庫直接託管在雲端服務上，從而促進全球協作和演算法訓練。例如，亞馬遜網路服務（AWS）於2025年10月宣布向AWS開放資料註冊表發布一個包含超過16,000個蛋白質-配體複合物分子動力學軌蹟的綜合儲存庫，以加速基於雲端的研究。

目錄

第1章概述

第2章：調查方法

第3章執行摘要

第4章：客戶心聲

第5章：全球分子動力學模擬軟體市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 按類型（GPU加速、CPU專用）
    • 依應用領域（化學研究、醫學研究、材料研究、生物物理研究）
    • 依最終用戶（製藥實驗室、研究機構、學術用戶、其他）分類
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

第6章：北美分子動力學模擬軟體市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國別分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲分子動力學模擬軟體市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國別分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太地區分子動力學模擬軟體市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國別分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：中東和非洲分子動力學模擬軟體市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東與非洲：國別分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美洲分子動力學模擬軟體市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國別分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進因素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 近期趨勢

第13章：全球分子動力學模擬軟體市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的議價能力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • SchrOdinger, Inc.
  • Dassault Systemes SE
  • Cadence Design Systems, Inc.
  • Bio-Rad Laboratories, Inc.
  • Optibrium, Ltd.
  • Chemical Computing Group ULC
  • GROMACS
  • CD ComputaBio
  • Simulations Plus, Inc.
  • Cresset Biomolecular Discovery Limited

第16章 策略建議

第17章：關於研究公司及免責聲明

簡介目錄
Product Code: 22440

The Global Molecular Dynamics Simulation Software Market is projected to increase from USD 662.13 Million in 2025 to USD 1536.35 Million by 2031, expanding at a CAGR of 15.06%. This software functions as a computational framework that predicts system behavior over specific timeframes by numerically solving Newton's equations of motion to model the physical movements of atoms and molecules. Market growth is primarily fueled by the urgent need for accelerated drug discovery pipelines in the pharmaceutical industry and the demand for precise material characterization in chemical engineering. Additionally, the growing availability of high-performance computing infrastructure enables facilities to simulate larger biological systems with higher fidelity, thereby reducing the reliance on capital-intensive physical experimentation.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 662.13 Million
Market Size 2031USD 1536.35 Million
CAGR 2026-203115.06%
Fastest Growing SegmentGPU-Accelerated
Largest MarketNorth America

Despite these advancements, the industry encounters significant hurdles regarding the curation and management of the massive, complex datasets produced during simulations. Data from the Pistoia Alliance indicates that in 2024, 52% of life science professionals cited low-quality and poorly curated datasets as the main barrier to the effective implementation of advanced computational research technologies. Consequently, the steep learning curve associated with ensuring data integrity and interoperability remains a critical obstacle that could potentially stall broader market scalability and adoption.

Market Driver

The surging adoption of simulation tools in pharmaceutical drug discovery and design is fundamentally reshaping the market, as companies prioritize computational methods to mitigate the high attrition rates associated with physical clinical trials. By leveraging molecular dynamics to simulate receptor-binding affinities, organizations can identify viable candidates earlier in the R&D cycle, which significantly lowers development costs. This strategic shift toward virtual experimentation is evidenced by substantial capital investments in simulation-focused biotech entities; for instance, Xaira Therapeutics announced in an April 2024 press release that it secured $1 billion in committed capital to build a platform that integrates biological data generation with advanced simulation product development to redefine the drug discovery pipeline.

In parallel, the integration of AI and machine learning algorithms is enhancing the predictive accuracy of molecular movements while drastically reducing computational time. These hybrid workflows allow researchers to bypass traditional brute-force calculations, enabling the rapid analysis of larger and more complex systems. According to a May 2024 technical blog by Google regarding 'AlphaFold 3,' their updated model demonstrated a 50% improvement in accuracy for protein-ligand interactions compared to specialized physics-based software tools. This efficiency is critical for broader market applications, such as advanced material engineering; Microsoft reported in 2024 that its Azure Quantum Elements platform utilized high-performance AI to screen 32 million potential inorganic materials in just 80 hours, showcasing the rapid scalability available to the industry.

Market Challenge

The difficulty of managing and curating massive, complex datasets acts as a primary restraint hindering the expansion of the Global Molecular Dynamics Simulation Software Market. As computational tools become more powerful, they generate vast quantities of output data that require rigorous organization and standardization to remain useful for future research. When organizations fail to establish cohesive data management frameworks, critical research information becomes trapped in isolated systems, making it difficult to validate simulation results or effectively train predictive models. This fragmentation forces research teams to spend valuable time on manual data rectification rather than high-value discovery, significantly reducing the operational efficiency that these software solutions promise to deliver.

This inefficiency creates a substantial barrier to entry and scalability for potential buyers. According to the Pistoia Alliance, in 2025, 57% of life science professionals identified data silos as the top challenge preventing the effective use of laboratory data. Because these silos impede the seamless flow of information required for advanced simulations, decision-makers are often reluctant to invest in premium software licenses. Consequently, the market experiences dampened growth rates as companies prioritize basic infrastructure remediation over the adoption of advanced simulation technologies.

Market Trends

The adoption of GPU-accelerated parallel processing architectures is fundamentally altering the computational landscape for molecular dynamics by enabling the simulation of larger biological systems with superior throughput. Hardware vendors are increasingly optimizing data center GPUs to handle the massive parallelization required for calculating inter-atomic forces in explicit solvent models, thereby overcoming the latency limitations of traditional CPU-based clusters. This hardware evolution allows research teams to execute microsecond-scale simulations of complex macromolecular structures, such as entire viral capsids, which were previously computationally prohibitive. According to Exxact Corporation's September 2025 'AMBER 24 NVIDIA GPU Benchmarks' report, the NVIDIA B200 SXM GPU delivered a simulation performance of 114 nanoseconds per day for the Satellite Tobacco Mosaic Virus system, representing a 40% speed increase compared to the RTX 4090.

Simultaneously, the migration to cloud-based high-performance computing platforms is democratizing access to these advanced simulation capabilities while solving the critical challenge of managing petabyte-scale trajectory data. By shifting workloads to the cloud, organizations can leverage elastic infrastructure to accommodate bursty simulation demands without the capital expenditure of maintaining on-premise supercomputers, while also gaining centralized access to standardized public datasets. This transition is fostering a new era of open science where massive repositories of simulation data are hosted directly on cloud services to facilitate global collaboration and algorithm training. For example, Amazon Web Services announced in October 2025 that it had released a comprehensive repository in the Registry of Open Data on AWS, featuring molecular dynamics trajectories for over 16,000 protein-ligand complexes to accelerate cloud-based research.

Key Market Players

  • SchrOdinger, Inc.
  • Dassault Systemes S.E.
  • Cadence Design Systems, Inc.
  • Bio-Rad Laboratories, Inc.
  • Optibrium, Ltd.
  • Chemical Computing Group ULC
  • GROMACS
  • CD ComputaBio
  • Simulations Plus, Inc.
  • Cresset Biomolecular Discovery Limited

Report Scope

In this report, the Global Molecular Dynamics Simulation Software Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Molecular Dynamics Simulation Software Market, By Type

  • GPU-Accelerated
  • Working Only on CPU

Molecular Dynamics Simulation Software Market, By Application

  • Chemical Research
  • Medical Research
  • Material Science Research
  • Biophysics Research

Molecular Dynamics Simulation Software Market, By End-user

  • Pharmaceutical Labs
  • Research Institutes
  • Academic Users
  • Others

Molecular Dynamics Simulation Software Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Molecular Dynamics Simulation Software Market.

Available Customizations:

Global Molecular Dynamics Simulation Software Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Molecular Dynamics Simulation Software Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Type (GPU-Accelerated, Working Only on CPU)
    • 5.2.2. By Application (Chemical Research, Medical Research, Material Science Research, Biophysics Research)
    • 5.2.3. By End-user (Pharmaceutical Labs, Research Institutes, Academic Users, Others)
    • 5.2.4. By Region
    • 5.2.5. By Company (2025)
  • 5.3. Market Map

6. North America Molecular Dynamics Simulation Software Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type
    • 6.2.2. By Application
    • 6.2.3. By End-user
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Molecular Dynamics Simulation Software Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Type
        • 6.3.1.2.2. By Application
        • 6.3.1.2.3. By End-user
    • 6.3.2. Canada Molecular Dynamics Simulation Software Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Type
        • 6.3.2.2.2. By Application
        • 6.3.2.2.3. By End-user
    • 6.3.3. Mexico Molecular Dynamics Simulation Software Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Type
        • 6.3.3.2.2. By Application
        • 6.3.3.2.3. By End-user

7. Europe Molecular Dynamics Simulation Software Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type
    • 7.2.2. By Application
    • 7.2.3. By End-user
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Molecular Dynamics Simulation Software Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Type
        • 7.3.1.2.2. By Application
        • 7.3.1.2.3. By End-user
    • 7.3.2. France Molecular Dynamics Simulation Software Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Type
        • 7.3.2.2.2. By Application
        • 7.3.2.2.3. By End-user
    • 7.3.3. United Kingdom Molecular Dynamics Simulation Software Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Type
        • 7.3.3.2.2. By Application
        • 7.3.3.2.3. By End-user
    • 7.3.4. Italy Molecular Dynamics Simulation Software Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Type
        • 7.3.4.2.2. By Application
        • 7.3.4.2.3. By End-user
    • 7.3.5. Spain Molecular Dynamics Simulation Software Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Type
        • 7.3.5.2.2. By Application
        • 7.3.5.2.3. By End-user

8. Asia Pacific Molecular Dynamics Simulation Software Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type
    • 8.2.2. By Application
    • 8.2.3. By End-user
    • 8.2.4. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Molecular Dynamics Simulation Software Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Type
        • 8.3.1.2.2. By Application
        • 8.3.1.2.3. By End-user
    • 8.3.2. India Molecular Dynamics Simulation Software Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Type
        • 8.3.2.2.2. By Application
        • 8.3.2.2.3. By End-user
    • 8.3.3. Japan Molecular Dynamics Simulation Software Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Type
        • 8.3.3.2.2. By Application
        • 8.3.3.2.3. By End-user
    • 8.3.4. South Korea Molecular Dynamics Simulation Software Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Type
        • 8.3.4.2.2. By Application
        • 8.3.4.2.3. By End-user
    • 8.3.5. Australia Molecular Dynamics Simulation Software Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Type
        • 8.3.5.2.2. By Application
        • 8.3.5.2.3. By End-user

9. Middle East & Africa Molecular Dynamics Simulation Software Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type
    • 9.2.2. By Application
    • 9.2.3. By End-user
    • 9.2.4. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Molecular Dynamics Simulation Software Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Type
        • 9.3.1.2.2. By Application
        • 9.3.1.2.3. By End-user
    • 9.3.2. UAE Molecular Dynamics Simulation Software Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Type
        • 9.3.2.2.2. By Application
        • 9.3.2.2.3. By End-user
    • 9.3.3. South Africa Molecular Dynamics Simulation Software Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Type
        • 9.3.3.2.2. By Application
        • 9.3.3.2.3. By End-user

10. South America Molecular Dynamics Simulation Software Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Type
    • 10.2.2. By Application
    • 10.2.3. By End-user
    • 10.2.4. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Molecular Dynamics Simulation Software Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Type
        • 10.3.1.2.2. By Application
        • 10.3.1.2.3. By End-user
    • 10.3.2. Colombia Molecular Dynamics Simulation Software Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Type
        • 10.3.2.2.2. By Application
        • 10.3.2.2.3. By End-user
    • 10.3.3. Argentina Molecular Dynamics Simulation Software Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Type
        • 10.3.3.2.2. By Application
        • 10.3.3.2.3. By End-user

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Molecular Dynamics Simulation Software Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. SchrOdinger, Inc.
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Dassault Systemes S.E.
  • 15.3. Cadence Design Systems, Inc.
  • 15.4. Bio-Rad Laboratories, Inc.
  • 15.5. Optibrium, Ltd.
  • 15.6. Chemical Computing Group ULC
  • 15.7. GROMACS
  • 15.8. CD ComputaBio
  • 15.9. Simulations Plus, Inc.
  • 15.10. Cresset Biomolecular Discovery Limited

16. Strategic Recommendations

17. About Us & Disclaimer